Work

A Phase 2 Clinical Trial of SGN-40 Monotherapy in Relapsed Diffuse Large B-Cell Lymphoma.

Year: 2008

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v112.11.1000.1000

Authors: Ranjana Advani, Sven De Vos, Stephen M. Ansell, Brad Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry Kaplan, David Dornan, Nancy Whiting, Jonathan Drachman, Andres Forero-Torres

Institutions: Stanford University, University of California, Los Angeles, Mayo Clinic, University of Wisconsin–Madison, Georgetown University, Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Washington University in St. Louis, Weill Cornell Medicine, Northwestern University, Genentech, Seagen (United States), University of Alabama at Birmingham

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2588041724

FWCI: 1.474

Cites:

Cited by: 10

Related to: 10